Deutsche Bank Aktiengesellschaft Cuts H. B. Fuller (NYSE:FUL) Price Target to $62.00

H. B. Fuller (NYSE:FUL – Free Report) had its price objective cut by Deutsche Bank Aktiengesellschaft from $72.00 to $62.00 in a research report released on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has a buy rating on the specialty chemicals company’s stock.

A number of other research firms also recently commented on FUL. Raymond James Financial set a $67.00 price target on shares of H. B. Fuller in a research report on Friday, June 26th. Citigroup decreased their price target on H. B. Fuller from $75.00 to $63.00 and set a “buy” rating for the company in a research report on Monday. Wall Street Zen cut shares of H. B. Fuller from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 25th. Zacks Research cut H. B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Friday, September 18th. Finally, UBS Group set a $69.00 price target on shares of H. B. Fuller in a research note on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $64.62.

Get Our Latest Analysis on FUL

H. B. Fuller Price Performance

Shares of NYSE FUL opened at $50.18 on Tuesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.82 and a quick ratio of 1.10. H. B. Fuller has a 1-year low of $46.70 and a 1-year high of $68.63. The business’s fifty day moving average price is $55.24 and its two-hundred day moving average price is $58.18. The firm has a market capitalization of $2.70 billion, a PE ratio of 13.98, a P/E/G ratio of 0.61 and a beta of 0.99.

H. B. Fuller (NYSE:FUL – Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The specialty chemicals company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.05. The firm had revenue of $938.17 million for the quarter, compared to the consensus estimate of $945.59 million. H. B. Fuller had a net margin of 5.56% and a return on equity of 12.65%. H. B. Fuller’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same period last year, the firm posted $1.26 EPS. On average, research analysts expect that H. B. Fuller will post 4.88 EPS for the current year.

H. B. Fuller Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 13th. Shareholders of record on Thursday, July 30th were issued a $0.2450 dividend. The ex-dividend date of this dividend was Thursday, July 30th. This represents a $0.98 dividend on an annualized basis and a yield of 2.0%. H. B. Fuller’s dividend payout ratio is 27.30%.

Insiders Place Their Bets

In other news, Director Teresa Rasmussen bought 2,042 shares of the firm’s stock in a transaction that occurred on Monday, September 28th. The shares were acquired at an average cost of $48.96 per share, with a total value of $99,976.32. Following the completion of the transaction, the director directly owned 4,053 shares in the company, valued at $198,434.88. This represents a 101.54% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel Florness acquired 2,030 shares of the firm’s stock in a transaction dated Monday, September 28th. The shares were purchased at an average cost of $49.34 per share, for a total transaction of $100,160.20. Following the acquisition, the director directly owned 3,381 shares in the company, valued at $166,818.54. This represents a 150.26% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 12,582 shares of company stock valued at $621,322 in the last quarter. 1.83% of the stock is currently owned by insiders.

Institutional Trading of H. B. Fuller

Several institutional investors have recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of H. B. Fuller during the fourth quarter worth approximately $44,203,000. Congruence Capital LLC bought a new stake in shares of H. B. Fuller during the fourth quarter worth $10,048,000. Kennedy Capital Management LLC lifted its position in H. B. Fuller by 43.4% during the 4th quarter. Kennedy Capital Management LLC now owns 630,194 shares of the specialty chemicals company’s stock valued at $37,471,000 after purchasing an additional 190,750 shares during the period. S&CO Inc. acquired a new position in H. B. Fuller in the second quarter valued at approximately $14,093,000. Finally, Eurizon Capital SGR S.p.A. acquired a new position in shares of H. B. Fuller in the 4th quarter valued at $2,283,000. Institutional investors and hedge funds own 95.93% of the company’s stock.

More H. B. Fuller News

Here are the key news stories impacting H. B. Fuller this week:

  • Positive Sentiment: Activist investor Ancora raised its offer for H. B. Fuller’s building adhesives unit to as much as $1.4 billion in cash. A higher bid, reportedly backed by Fortress, improves the prospects of a sale that could unlock value and increases pressure on H. B. Fuller’s board to consider strategic alternatives. Ancora raises bid for H.B. Fuller building unit
  • Positive Sentiment: Multiple directors purchased approximately $620,000 of FUL shares. Recent buyers included Celine Martin, Michael Happe, Srilata Zaheer, Charles T. Lauber, Teresa Rasmussen, Daniel L. Florness and Thomas W. Handley, with purchases generally priced near $49 to $50 per share. The transactions substantially increased several directors’ holdings and may signal confidence in the company’s valuation. H. B. Fuller insider purchase filing
  • Neutral Sentiment: Recent quarterly results offered some fundamental support. H. B. Fuller reported adjusted EPS of $1.52, ahead of the $1.47 consensus, while revenue rose 5.2% year over year to roughly $938 million. However, revenue fell modestly short of expectations, limiting the positive impact of the earnings report.
  • Negative Sentiment: Analyst caution could restrain the stock. JPMorgan and Deutsche Bank issued less optimistic outlooks, while Deutsche Bank reportedly reduced its price target, highlighting concerns about valuation and the company’s operating outlook despite continued expectations for potential upside. Analyst outlook for H. B. Fuller

H. B. Fuller Company Profile

(Get Free Report)

H.B. Fuller Company is a global manufacturer of adhesives, sealants and specialty chemical products. Its solutions are used to bond, seal, protect and assemble materials in commercial and industrial applications, including packaging, hygiene products, construction, transportation, electronics and durable goods.

The company offers products such as hot-melt, water-based and reactive adhesives, construction adhesives, sealants, coatings and specialty formulations. H.B. Fuller serves manufacturers, contractors and other commercial customers that require bonding and sealing solutions for products, components and building materials.

Founded in 1887 by Harvey Benjamin Fuller, the company has grown from a regional adhesive producer into an international supplier serving customers across North America, Europe, Asia-Pacific and Latin America.

Further Reading

Analyst Recommendations for H. B. Fuller (NYSE:FUL)

Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.